Exposure to antiretroviral agents during pregnancy does not alter bone status in infants

Bone

Volumn 50, Issue 1, 2012, Pages 255-258

  Mora, Stefano ^a   Giacomet, Vania ^b   Viganò, Alessandra ^b   Cafarelli, Laura ^b   Stucchi, Sara ^b   Pivetti, Valentina ^b   Manfredini, Valeria ^b   Puzzovio, Maria ^a   Zuccotti, Gianvincenzo ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Antiviral treatment; Bone alkaline phosphatase; C terminal telopeptide of type I collagen; HIV; Infants; Quantitative ultrasonography

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ALKALINE PHOSPHATASE; ANTIRETROVIRUS AGENT; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; DIDANOSINE; DIDANOSINE PLUS LAMIVUDINE; EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; TENOFOVIR; UNCLASSIFIED DRUG;

ARTICLE; BONE DISEASE; BONE LEVEL; BONE TISSUE; CHILDBIRTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL BONE; ECHOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LONGITUDINAL STUDY; MALE; METABOLIC BONE DISEASE; NEWBORN; OSSIFICATION; OSTEOLYSIS; PRENATAL EXPOSURE; QUANTITATIVE ANALYSIS; TIBIA; UMBILICAL CORD BLOOD;

ADULT; ANTI-RETROVIRAL AGENTS; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; TIBIA;

EID: 81255178826     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.10.030     Document Type: Article

References (22)

1. van Sighem A.I., Gras L.A., Reiss P., Brinkman K., de Wolf F. ATHENA national observational cohort study. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS 2010, 24:1527-1535.
2. Mnyani C.N., McIntyre J.A. Preventing mother-to-child transmission of HIV. BJOG 2009, 116(Suppl. 1):71-76.
3. Townsend C.L., Cortina-Borja M., Peckham C.S., de Ruiter A., Lyall H., Tookey P.A. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008, 22:973-981.
4. The Italian Registry for HIV Infection in Children. Update report April 2009.
5. Mora S., Zamproni I., Zuccotti G., Viganò A. Pediatric HIV infection and bone health: an emerging challenge. Front Biosci (Elite Ed) 2010, 2:1265-1274.
6. Stone B., Dockrell D., Bowman C., Mccloskey E. HIV and bone disease. Arch Biochem Biophys 2010, 503:66-77.
7. Tarantal A.F., Marthas M.L., Shaw J.P., Cundy K., Bischofberger N. Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 20:323-333.
8. Tarantal A.F., Castillo A., Ekert J.E., Bischofberger N., Martin R.B. Foetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). J Acquir Immune Defic Syndr 2002, 29:207-220.
9. Giaquinto C., Penazzato M., Rosso R., Bernardi S., Rampon O., et al. Italian consensus statement on paediatric HIV infection. Infection 2010, 38:301-319. The Italian Paediatric HIV Infection Working Group.
10. Jones G., Riley M., Dwyer T. Maternal smoking during pregnancy, growth, and bone mass in prepubertal children. J Bone Miner Res 1999, 14:146-151.
11. Keiver K., Herbert L., Weinberg J. Effect of maternal ethanol consumption on maternal and fetal calcium metabolism. Alcohol Clin Exp Res 1996, 20:1305-1312.
12. Keiver K., Ellis L., Anzarut A., Weinberg J. Effect on prenatal ethanol exposure on fetal calcium metabolism. Alcohol Clin Exp Res 1997, 21:1612-1618.
13. Nakamoto T., Grant S., Yazdani M. The effects of maternal caffeine intake during pregnancy on mineral contents of fetal rat bone. Res Exp Med (Berlin) 1989, 189:275-280.
14. Cooper C., Javaid K., Westlake S., Harvey N., Dennison E. Developmental origins of osteoporotic fracture: the role of maternal vitamin D insufficiency. J Nutr 2005, 135:2728S-2734S.
15. Javaid M.K., Crozier S.R., Harvey N.C., Gale C.R., Dennison E.M., Boucher B.J., et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006, 367:36-43.
16. Land C., Schoenau E. Fetal and postnatal bone development: reviewing the role of mechanical stimuli and nutrition. Best Pract Res Clin Endocrinol Metab 2008, 22:107-118.
17. Mora S., Sala N., Bricalli D., Zuin G., Chiumello G., Viganò A. Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy. AIDS 2001, 15:1823-1829.
18. Mora S., Zamproni I., Beccio S., Bianchi R., Giacomet V., Viganò A. Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children. J Clin Endocrinol Metab 2004, 89:24-28.
19. Mora S., Zamproni I., Cafarelli L., Giacomet V., Erba P., Zuccotti G., et al. Alterations in circulating osteoimmune factors may be responsible for high bone resorption rate in HIV-infected children and adolescents. AIDS 2007, 21:1129-1135.
20. Zuccotti G., Viganò A., Gabiano C., Giacomet V., Mignone F., Stucchi S., et al. Antiretroviral therapy and bone mineral measurements in HIV-infected youths. Bone 2010, 46:1633-1638.
21. Zuccotti G., Viganò A., Cafarelli L., Pivetti V., Pogliani L., Puzzovio M., et al. Longitudinal changes of bone ultrasound measurements in healthy infants during the first year of life: influence of gender and type of feeding. Calcif Tissue Int 2011, 89:312-317.
22. Liao X.P., Zhang W.L., He J., Sun J.H., Huang P. Bone measurements of infants in the first 3months of life by quantitative ultrasound: the influence of gestational age, season, and postnatal age. Pediatr Radiol 2005, 35:847-853.